Abstract
Nuclear factor (NF)—κB is involved in regulating the transcription of many of the immunomodulatory mediators involved in the development of sepsis-induced organ failure. Kinase pathways involving p38 and Akt and initiated by engagement of Toll-like receptors modulate transcriptional activity of NF-κB, but apparently through different mechanisms. Increased activation of NF-κB occurs with sepsis, and greater levels of nuclear accumulation of NF-κB are associated with higher rates of mortality and worse clinical outcome. The percentage of apoptotic neutrophils is reduced in sepsis, and inhibition of nuclear translocation of NF-κB restores neutrophil apoptosis to baseline levels. In models of sepsis, suppression of NF-κB activation decreases acute inflammatory processes and organ dysfunction. Because NF-κB occupies a central role in signaling pathways important in sepsis, modulation of NF-κB activity may be an appropriate therapeutic target in patients with sepsis.